首页 > 市场调查报告书 > 製药

感染疾病

市场调查报告书

商品编码

1358084

抗真菌药物市场：按药物类型、按适应症、按剂型、按配销通路、按地区

Anti Fungal Drugs Market, By Drug Type, By Indication, By Dosage Form, By Distribution Channel, By Geography

出版日期: 2023年08月31日 | 出版商:

Coherent Market Insights | 英文 164 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计到 2023 年，全球抗真菌药物市场价值将达到 140 亿美元，预测期内（2023-2030 年）年复合成长率为 3.5%。

报告范围		报告详情
基准年	2022年	2023年市场规模	140亿美元
实绩资料	2018-2021	预测期	2023-2030
预测期年复合成长率	3.50%	2030年市场规模预测	178亿美元

抗真菌药物全球市场占有率(%)（按药物类型），2023 年

抗真菌药物是选择性消除宿主真菌病原体同时将对宿主的毒性降至最低的药物。抗真菌药物治疗真菌感染疾病。土壤、空气和皮肤中存在的真菌可引起酵母菌感染疾病、癣以及指甲和皮肤感染疾病。吸入真菌孢子会导致呼吸道疾病。真菌感染疾病会影响循环系统、呼吸系统、皮肤和指甲。抗真菌药物可以杀死真菌。抗真菌药物可以杀死真菌或阻止其繁殖或生长。抗真菌药物有多种类别和不同类型。使用抗真菌药物治疗的常见真菌感染疾病包括癣、足癣、指甲真菌感染疾病、阴道鹅口疮和严重类型的头皮屑。抗真菌药物以两种方式发挥作用：直接杀死真菌细胞，并阻止真菌细胞生长或繁殖。抗真菌药物可以在不损害人体细胞的情况下对抗真菌感染，因为它们针对的是真菌细胞所需的结构和功能，而不是人体细胞所需的结构和功能。两种常见的目标结构是真菌细胞膜和真菌细胞壁。两者都是围绕和保护真菌细胞的结构。如果其中任何一个受到损坏，真菌细胞就会破裂并死亡。

市场动态

市场主要参与者增加产品推出预计将在预测期内推动全球抗真菌药物市场的成长。例如，2022年4月，製药公司Dr. Reddy's Laboratories宣布在美国市场推出泊沙康唑延迟释放片。泊沙康唑用于预防免疫力严重衰弱的患者（例如接受化疗的患者）的某些真菌感染。有一类药物称为唑类抗真菌药物。它的作用是抑制真菌的生长。

本研究的主要特点

本报告详细分析了全球抗真菌药物市场，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和复合年度（年复合成长率）。它还强调了各个细分市场的潜在收益成长机会，并为该市场说明了一系列有吸引力的投资提案。
它还提供了有关市场促进因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
根据公司亮点、产品系列、主要亮点、绩效和策略等参数对全球抗真菌药物市场的主要参与者进行了分析。
该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的资讯。
全球抗真菌药物市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进入者和财务分析师。
相关人员可以透过用于分析全球抗真菌药物市场的各种策略矩阵来促进决策。

Report Coverage	Report Details
Base Year:	2022	Market Size in 2023:	US$ 14.0 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	3.50%	2030 Value Projection:	US$ 17.8 Bn

An antifungal agent is a drug that selectively eliminates fungal pathogens from a host with minimal toxicity to the host. Antifungal medicines treat fungal infections. Fungus in the soil, air, and on the skin can cause yeast infections, ringworm, and nail and skin infections. Breathing in fungal spores can lead to respiratory illnesses. Fungal infections can affect the circulatory system, respiratory system, and the skin and nails. Antifungal medicines can kill a fungus. Or they may stop it from multiplying or growing. There are several classes of antifungal medications and different types of medicines. Common fungal infections treated with anti-fungal medication include ringworm, athlete's foot, fungal nail infection, vaginal thrush, severe type of dandruff, and others. Antifungal drugs can work in two ways: by directly killing fungal cells or by preventing fungal cells from growing and thriving. Antifungal drugs target structures or functions that are necessary in fungal cells but not in human cells, so they can fight a fungal infection without damaging the body's cells. Two structures that are commonly targeted are the fungal cell membrane and the fungal cell wall. Both of these structures surround and protect the fungal cell. When either one becomes compromised, the fungal cell can burst open and die.

Market Dynamics

Increasing product launches by the key players in the market are expected to drive the growth of the global anti fungal drugs market over the forecast period. For instance, in April 2022, Dr. Reddy's Laboratories, a pharmaceutical company, announced the launch of the Posaconazole delayed-release tablets in the U.S. market. Posaconazole is used to prevent certain fungal infections in patients who have severely weakened immune systems (such as patients who have had chemotherapy). It belongs to a class of drugs known as azole antifungals. It works by stopping the growth of fungi.

Key features of the study:

This report provides an in-depth analysis of the global anti fungal drugs market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year. It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global anti fungal drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Te key companies covered as a part of this study include GlaxoSmithKline Plc, Bayer AG, Abbott Laboratories, Merck & Co., Inc, Glenmark Pharmaceuticals Limited, Enzon Pharmaceuticals, Inc., Pfizer Inc., Gilead Sciences, Inc., Sanofi S.A., and Astellas Pharma, Inc., Alembic Pharmaceuticals Limited, and SCYNEXIS, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global anti fungal drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anti fungal drugs market

Detailed Segmentation:

By Drug Type:
- Echinocandins
- Polyenes
- Allylamines
- Azoles
- Others
By Application:
- Neurosurgery
- Plastic Surgery
- Cardiovascular Surgery
- Obstetrics & Gynecology
- Others
By Indication:
- Aspergillosis
- Dermatophytosis
- Candidiasis
- Mucormycosis
- Others
By Dosage Form :
- Powders
- Ointments
- Injections
- Tablets
- Others
By Distribution Channel:
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- GlaxoSmithKline Plc.
- Bayer AG
- Abbott Laboratories
- Merck & Co., Inc
- Glenmark Pharmaceuticals Limited
- Enzon Pharmaceuticals, Inc.
- Pfizer Inc.
- Gilead Sciences, Inc.
- Sanofi S.A.
- Astellas Pharma, Inc.
- Alembic Pharmaceuticals Limited
- SCYNEXIS, Inc

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Indication
- Market Snippet, By Dosage Form
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Test Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Anti Fungal Drugs Market - COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Anti Fungal Drugs Market, By Drug Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Echinocandins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Polyenes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Allylamines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Azoles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

6. Global Anti Fungal Drugs Market, By Indication, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Aspergillosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Dermatophytosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Candidiasis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Mucormycosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

7. Global Anti Fungal Drugs Market, By Dosage Form, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Powders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Ointments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Injections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)

8. Global Anti Fungal Drugs Market, By Distribution Channel, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)

9. Global Anti Fungal Drugs Market, By Region, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication,2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication,2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication,2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication,2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication,2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Drug Type, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication,2018 - 2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Dosage Form, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018 - 2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
North Africa
Central Africa
South Africa

10. Competitive Landscape

Company Profiles
- GlaxoSmithKline Plc
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Bayer AG
- Abbott Laboratories
- Merck & Co., Inc
- Glenmark Pharmaceuticals Limited
- Enzon Pharmaceuticals, Inc
- Pfizer Inc
- Gilead Sciences, Inc
- Sanofi S.A.
- Astellas Pharma, Inc
- Alembic Pharmaceuticals Limited
- SCYNEXIS, Inc

11. Section

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

抗真菌药物市场：按药物类型、按适应症、按剂型、按配销通路、按地区

Anti Fungal Drugs Market, By Drug Type, By Indication, By Dosage Form, By Distribution Channel, By Geography

市场动态

本研究的主要特点

目录

第1章调查目的和假设

第2章市场展望

第3章市场动态、法规及趋势分析

第4章全球抗真菌药物市场－新型冠状病毒感染疾病（COVID-19）影响分析

第5章全球抗真菌药物市场：依药物类型，2018-2030

第6章全球抗真菌药物市场：依适应症分类，2018-2030

第7章全球抗真菌药物市场：按剂型，2018-2030

第8章全球抗真菌药物市场：依配销通路划分，2018-2030

第9章全球抗真菌药物市场：按地区划分，2018-2030

第10章竞争形势

第11章章节